Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pork myofibrillar proteins are a complex mixture of salt-soluble proteins derived from the skeletal muscle of pigs (Sus scrofa), primarily consisting of myosin (50-55%), actin (20-25%), and regulatory proteins such as tropomyosin and troponins [1]. These proteins are organized into thick and thin filaments within the sarcomere, the basic functional unit of muscle, where they facilitate contraction through ATP-dependent cross-bridge cycling [2]. In the field of food science and technology, these proteins are highly valued for their functional properties, including their ability to form heat-induced gels and emulsify fats, which are crucial for the texture and quality of processed pork products [3]. From a medical perspective, pork myofibrillar proteins are not considered therapeutic targets for drug intervention; instead, they are studied in the context of nutrition and food hypersensitivity [4]. While rare, certain individuals may develop IgE-mediated allergies to these proteins, sometimes associated with cross-reactivity in pork-cat syndrome, where patients sensitized to cat dander react to porcine muscle proteins [5]. Sources: [1] Joo, S. T., et al. (2013). "Meat Science and Muscle Biology." [2] UniProt Consortium. "Myosin-4 (Sus scrofa)." [3] Sun, X. D., & Holley, R. A. (2011). "Factors Influencing Gel Formation by Myofibrillar Proteins." [4] NIH. "Food Allergy." [5] Posthumus, J., et al. (2013). "Pork-Cat Syndrome: An under-recognized cause of meat allergy."
Not applicable as this is a food component and not a therapeutic drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pork myofibrillar protein (MP).